Eco R1 Capital, LLC Aligos Therapeutics, Inc. Transaction History

Eco R1 Capital, LLC

  • $2.31 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.56 - $0.8 $1.37 Million - $1.95 Million
2,441,108 Added 61.83%
6,389,468 $4.22 Million
Q1 2022

May 16, 2022
BUY
$2.08 - $12.2 $8.02 Million - $47.1 Million
3,857,316 Added 4236.76%
3,948,360 $8.49 Million
Q4 2021

Feb 14, 2022
BUY
$11.48 - $17.69 $1.05 Million - $1.61 Million
91,044 New
91,044 $1.08 Million

Others Institutions Holding ALGS

# of Institutions
1
Shares Held
227K
Call Options Held
0
Put Options Held
0
View Full List

About Aligos Therapeutics, Inc.

ALGS Quotes by TradingView
  • Ticker ALGS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,717,000
  • Market Cap $1.3B
  • Description
  • Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...
More about ALGS
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email